For the quarter ending 2025-09-30, AIFF had -$1,593K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -2,639 | -14,763 |
| Depreciation and amortization | 58 | 62 |
| Impairment of intangible asset | 152 | - |
| Share-based compensation expense | 215 | 324 |
| Accretion expense on convertible promissory note | 0 | 126 |
| Change in derivative fair value | 0 | -9,369 |
| Loss on settlement of convertible promissory note | 0 | -1,353 |
| Loss on shares issued for debt | 0 | -217 |
| Expense recognized from prepaid credits used originally issued with shares | 601 | - |
| Shares issued for consulting services | 0 | 32 |
| Change in receivables | -13 | 31 |
| Change in prepaid expenses | -312 | 67 |
| Change in inventory | -28 | 37 |
| Change in trade payables | -157 | -475 |
| Change in accrued liabilities | 126 | -1,184 |
| Drawdown in shares issued for prepaid services | - | 140 |
| Change in deferred revenue | -57 | 33 |
| Product enhancement intangible asset | - | 0 |
| Net cash used in operating activities | -1,488 | -4,901 |
| Acquisition of new business, net of cash acquired | 0 | 2,360 |
| Purchase of equipment | 86 | 19 |
| Net cash used in investing activities | -86 | -2,379 |
| Proceeds from sale of shares, net of issuance costs | -29 | 2,560 |
| Proceeds from exercise of warrants | 10 | 8,828 |
| Net cash provided by financing activities | -19 | 11,388 |
| Increase (decrease) in cash | -1,593 | 4,108 |
| Cash and cash equivalents at beginning of period | 1,810 | - |
| Cash and cash equivalents at end of period | 4,325 | - |
FIREFLY NEUROSCIENCE, INC. (AIFF)
FIREFLY NEUROSCIENCE, INC. (AIFF)